Research Topics
| Amy J GrizzleSummaryAffiliation: University of Arizona Country: USA Publications
| Collaborators
|
Detail Information
Publications
Reasons provided by prescribers when overriding drug-drug interaction alertsAmy J Grizzle
Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721 0202, USA
Am J Manag Care 13:573-8. 2007..To investigate prescribers' rationales for overriding drug-drug interaction (DDI) alerts and to determine whether these reasons were helpful to pharmacists as a part of prescription order verification...- Potential drug-drug interactions within Veterans Affairs medical centersMaysaa Mahmood
Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona UA, Tucson, AZ 85721 0202, USA
Am J Health Syst Pharm 64:1500-5. 2007..This study assessed the prevalence of 25 clinically important drug-drug interactions (DDIs) in the ambulatory care clinics of the Department of Veterans Affairs medical centers (VAMCs)... 
Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluationLisa E Hines
The Center for Health Outcomes and PharmacoEconomic Research, University of Arizona College of Pharmacy, 1295 N Martin Avenue, PO Box 210202, Tucson, AZ 85721 0202, USA
Res Social Adm Pharm 7:359-68. 2011....- Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactionsDaniel C Malone
Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721 0207, USA
J Am Pharm Assoc (2003) 44:142-51. 2004..To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system... - Workload and availability of technology in metropolitan community pharmaciesGrant H Skrepnek
Center for Health Outcomes and PharmarcoEconomic Research, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA
J Am Pharm Assoc (2003) 46:154-60. 2006..To assess workload characteristics and the presence of prescription processing technologies within metropolitan community pharmacies in the United States... - Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactionsDaniel C Malone
College of Pharmacy, University of Arizona, Tucson 85721, USA
Med Care 45:456-62. 2007..The purpose of this study was to examine pharmacy characteristics that may be associated with dispensed potential DDIs... - Assessment tool for pharmacy drug-drug interaction softwareTerri L Warholak
College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
J Am Pharm Assoc (2003) 51:418-24. 2011..To assess the performance of pharmacy clinical decision support (CDS) systems for drug-drug interaction (DDI) detection and to identify approaches for improving the ability to recognize important DDIs... - Community pharmacy managers' perception of computerized drug-drug interaction alertsJacob Abarca
Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, P O Box 210207, Tucson, AZ 85721 0207, USA
J Am Pharm Assoc (2003) 46:148-53. 2006..To examine community pharmacists' attitudes toward computerized drug-drug interaction (DDI) alerts and identify factors associated with more favorable perceptions of these alerts... - Development of computerized alerts with management strategies for 25 serious drug-drug interactionsJohn E Murphy
College of Pharmacy, The University of Arizona, Tucson, AZ 85721 0202, USA
Am J Health Syst Pharm 66:38-44. 2009..The development of computerized alerts with management strategies for 25 drug-drug interactions (DDIs) is described... 
Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactionsKim R Saverno
Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, Arizona 85721 0202, USA
J Am Med Inform Assoc 18:32-7. 2011..However, studies indicate these systems may miss some important interactions. The purpose of this study was to assess the performance of pharmacy CDS programs to detect clinically important DDIs...- Industry's perception of presenting pharmacoeconomic models to managed care organizationsBridget M Olson
University of Arizona College of Pharmacy, 1703 East Mabel St, Room 318, PO Box 210207, Tucson, AZ 85721, USA
J Manag Care Pharm 9:159-67. 2003..Previous research has shown that pharmacoeconomic (PE) data are considered important but may not be optimally utilized by decision makers. No research has compared the effectiveness of different types of PE models... - Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart auditJacob Abarca
University of Arizona College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, 1703 E Mabel, P O Box 210207, Tucson, AZ 85721 0207, USA
J Manag Care Pharm 10:538-42. 2004..To describe the dosing of etanercept and infliximab for the treatment of rheumatoid arthritis (RA)... - Concordance of severity ratings provided in four drug interaction compendiaJacob Abarca
Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson 85721-0207, USA
J Am Pharm Assoc (2003) 44:136-41. 2004..A concerted effort to identify DDIs of the highest clinical importance is needed to design effective strategies to avoid and manage them... - Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic reviewEleanor L Olvey
University of Arizona College of Pharmacy, Tucson, Arizona 85721 0202, USA
Clin Ther 32:2282-303. 2010..Treatments targeted at reducing this spasticity have evolved over time...